期刊文献+

Gentier96全自动医用PCR分析系统检测HBV-DNA及HCV-RNA的性能验证

A Performance Verification of a Gentier96 Automatic Medical PCR Analytic System via Quantitative Tests on HBV-DNA and HCV-RNA
下载PDF
导出
摘要 目的 对实验室新购入设备Gentier96全自动医用PCR分析系统使用HBV-DNA及HCV-RNA定量检测项目进行性能验证。方法 通过检测HBV-DNA及HCV-RNA定量检测项目,对精密度、正确度、线性范围及抗干扰能力进行验证和评价。结果 该系统检测低水平和高水平HBV-DNA的实验室变异系数(CV)分别为4.12%、1.27%。低水平和高水平HCV-RNA的实验室变异系数(CV)分别为4.75%、1.46%。HBV-DNA国家标准物质GBW(E)090137(浓度编号S5)靶值的对数值3.15、GBW(E)090139(浓度编号S2)靶值的对数值6.66。HCV-RNA国家标准物质GBW(E)090140(浓度编号S5)靶值的对数值3.34、GBW(E)090142(浓度编号S3)靶值的对数值5.64,实测值与靶值的差异均在±0.4对数值范围内。该分析系统HBV-DNA定量检测在4.69×10~2.04×109范围内呈线性,线性回归方程为Y=0.9884X+0.1452,R2=0.9994。HCV-RNA定量检测在3.47×10~2.33×107范围内呈线性,线性回归方程为Y=0.9548X+0.3302,R2=0.9997。干扰物质血红蛋白(Hb)样本与对照组样本偏倚<±7.5%,表明常见抗干扰物质血红蛋白(Hb)浓度≤2g/dL时对HBV-DNA和HCV-RNA定量检测结果无影响。结论 Gentier96全自动医用PCR分析系统检测HBV-DNA及HCV-RNA已达到相关标准要求,可用于样本检测。 Objective The current research aimed to verify the performance of newly purchased laboratory equipment,namely,a gentier96 automatic medical PCR analytic system,through quantitative tests on HBV-DNA and HCV-RNA.Methods The precision,accuracy,linear range,and anti-jamming capability of the system were verified and evaluated through quantitative tests on HBV-DNA and HCV-RNA.Results The within-laboratory coefficients of variation(CV s)for low and high levels of the system were 4.12%and 1.27%,respectively,when testing HBV-DNA.The within-laboratory CV s for low and high levels of the system when testing HCV-DNA were 4.75%and 1.46%,respectively.The logarithmic values of target values for national standard reference materials GBW(E)090137(concentration no.S5)and GBW(E)090139(concentration no.S2)of HBV-DNA were 3.15 and 6.66,respectively.The logarithmic values of target values for national standard reference materials GBW(E)090140(concentration no.S5)and GBW(E)090142(concentration no.S3)of HCV-RNA were 3.34 and 5.64,respectively.The differences between the measured values and the target values were all within the logarithmic value of±0.4.The quantitative test results of the analytic system on HBV-DNA were linear within 4.69×10-2.04×109,and the linear regression equation was Y=0.9884 X+0.1452(R 2=0.9994).The results on HCV-RNA were linear within 3.47×10-2.33×107,and the linear regression equation was Y=0.9548 X+0.3302(R 2=0.9997).Samples of the interferent hemoglobin(Hb)showed a bias smaller than±7.5%with samples in the control group,which indicated that Hb at concentrations not larger than 2 g/dL did not influence the quantitative test results on HBV-DNA and HCV-RNA.Conclusion The current research verifies that the Gentier96 automatic medical PCR analytic system can reach the relevant standards and requirements for testing HBV-DNA and HCV-RNA,and therefore it can be used to test samples.
作者 耿见忠 张军会 刘江 尤珊 陈兰 郝家明 GENG Jianzhong;ZHANG Junhui;LIU Jiang;YOU Shan;CHEN Lan;HAO Jiaming(Guizhou Ankang Clinical Laboratories Inc,Guiyang 550016,China)
出处 《标记免疫分析与临床》 CAS 2023年第4期680-684,689,共6页 Labeled Immunoassays and Clinical Medicine
基金 中央引导地方科技发展资金项目(编号:黔科中引地[2021]4007) 贵阳市科技计划项目(编号:筑科合同[2022]-4-15号) 贵州安康医学检验中心科研项目(编号:AK[2021]003)。
关键词 PCR分析系统 HBV-DNA HCV-RNA 性能验证 PCR analytic system HBV-DNA HCV-RNA Performance verification
  • 相关文献

参考文献5

二级参考文献64

  • 1Peng Hu,Jia Shang,Wenhong Zhang,Guozhong Gong,Yongguo Li,Xinyue Chen,Jianning Jiang,Qing Xie,Xiaoguang Dou,Yongtao Sun,Yufang Li,Yingxia Liu,Guozhen Liu,Dewen Mao,Xiaoling Chi,Hong Tang,Xiaoou Li,Yao Xie,Xiaoping Chen,Jiaji Jiang,Ping Zhao,Jinlin Hou,Zhiliang Gao,Huimin Fan,Jiguang Ding,Dazhi Zhang,Hong Ren.HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog:New Switch Study[J].Journal of Clinical and Translational Hepatology,2018,6(1):25-34. 被引量:93
  • 2Rakhi Maiwall,Manoj Kumar.Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation[J].Journal of Clinical and Translational Hepatology,2016,4(1):54-65. 被引量:20
  • 3Lai CL,Shouval D,Lok AS,陈楠(摘译),张占卿(审校).恩替卡韦与拉米夫定治疗HBeAg阴性慢性乙型肝炎的对照研究[J].世界感染杂志,2006,6(4):396-396. 被引量:201
  • 4杨有业,张秀明.临床检验方法学评价[M].北京:人民卫生出版社,2008:118-127.
  • 5International Organization for Standardization. In Vitro Diagnostic Medical Devices- Measurement of Quantities in Samples of Biological Origin-Description of Reference Materials. ISO 15194, 2003.
  • 6International Organization for Standardization. Clinical Laboratory Medicine-Requirements for Reference Measurement Laboratories. 1SO 15195,2003.
  • 7International Organization for Standardization. General Requirements for the Competence of Testing and Calibration Laboratories. ISO 17025, 1999.
  • 8International Organization for Standardization. Medical Laboratories-Particular Requirements for Quality and Competence. ISO 15189, 2003.
  • 9Dybkaer R. Vocabulary for use in measurement procedures and description of reference materials in laboratory medicine. Eur J Clin Chem Clin Biochem ,1997, 35 : 141-173.
  • 10JJF1001—1998.通用计量术语及定义.中华人民共和国国家计量技术规范.[S].国家质量技术监督局,..

共引文献616

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部